Long-term survival of T1 and T2 lymph node-negative breast cancer patients according to mitotic activity index: A population-based study
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference42 articles.
1. Prognostic value of proliferation in invasive breast cancer: a review
2. Systemic Therapy in Resectable Breast Cancer
3. Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?
4. , . Malignant tumors of the breast. In: , . Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven, 1997. 1557–616.
5. Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer;Breast Cancer Research and Treatment;2014-12-21
2. Prognostic Factors and Recurrence in Breast Cancer: Experience at the National Cancer Institute of Mexico;ISRN Oncology;2012-07-05
3. Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less;BMC Cancer;2010-10-15
4. Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer;British Journal of Cancer;2008-07
5. Using evolvable genetic cellular automata to model breast cancer;Genetic Programming and Evolvable Machines;2007-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3